Intranasal Human Milk as Stem Cell Therapy in Preterm Infants with Intraventricular Hemorrhage: Safety, Feasibility and Short-Term Outcomes
Saturday, April 23, 2022
10:15 AM – 10:30 AM US MT
Location: Convention Center: Mile High Ballroom 4CD
CE: Enduring CME: 0.25
Publication Number: 1225.2
Alessia Gallipoli, University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada; Rebecca Hoban, The Hospital for Sick Children, Toronto, ON, Canada; Mark LePine, The Hospital for Sick Children, TORONTO, ON, Canada; Sharon Unger, Sinai Health, Toronto, ON, Canada
Presenting Author(s)
Alessia Gallipoli, MD
Neonatal-Perinatal Medicine Fellow The Hospital for Sick Children Toronto, Ontario, Canada
Participants should be aware of the following financial/non-financial relationships:
Alessia Gallipoli, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rebecca Hoban, MD MPH: ● Medela (Ended In the Past 24 Months) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness).
Mark LePine, MASTERS OF SCIENCE: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sharon Unger, MD, FRCP(C): I do not have any relevant financial / non-financial relationships with any proprietary interests.
